BRIEF published on 06/12/2024 at 14:41, 2 years ago Vidac Pharma Holding Plc: Research Initiation by Sphene Capital GmbH with a Buy Rating Oncology BUY Rating Biopharmaceutical Clinical-stage Vidac Pharma
PRESS RELEASE published on 06/12/2024 at 14:36, 2 years ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Sphene Capital initiates coverage on Vidac Pharma Holding Plc with a Buy rating and a price target of EUR 4.90. Vidac Pharma focuses on reversing cancer cell metabolism for oncology treatments BUY Rating Sphene Capital GmbH Vidac Pharma Holding Plc Cancer Cell Metabolism Oncology Treatments
Published on 06/23/2026 at 09:05, 27 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 06:45, 2 hours 47 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:01, 3 hours 31 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 7 hours 37 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 10 hours 7 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/23/2026 at 09:00, 32 minutes ago Hong Kong unlocks new opportunities with Central Asia
Published on 06/23/2026 at 08:55, 37 minutes ago JMGO Unveils Prime Day Savings of Up to 50% Across Its Triple-Laser Projector Lineup from June 23 to July 3
Published on 06/22/2026 at 18:00, 15 hours 32 minutes ago GUILLEMOT CORPORATION: STATEMENT REGARDING THE PASSING OF Mr. CLAUDE GUILLEMOT, CHAIRMAN OF GUILLEMOT CORPORATION GROUP
Published on 06/22/2026 at 08:30, 1 day 1 hour ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
